3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
46
Squamous Cell Carcinoma of Head and Neck
23
Lung Neoplasms
22
Oropharyngeal Neoplasms
13
Urinary Bladder Neoplasms
12
Nasopharyngeal Carcinoma
12
Carcinoma
11
Parkinson Disease 4, Autosomal Dominant Lewy Body
8
Biliary Tract Neoplasms
8
Uterine Cervical Neoplasms
7
Head and Neck Neoplasms
7
Pancreatic Neoplasms
6
Neoplasms
6
Esophageal Squamous Cell Carcinoma
6
Colorectal Neoplasms
6
Cholangiocarcinoma
6
Small Cell Lung Carcinoma
5
Neoplasm Metastasis
5
Mouth Neoplasms
5
Endometrial Neoplasms
5
Stomach Neoplasms
4
Laryngeal Neoplasms
4
Esophageal Neoplasms
4
Carcinoma, Squamous Cell
4
Ovarian Neoplasms
3
Neoplasms by Site
3
Mesothelioma, Malignant
3
Lymphoid Interstitial Pneumonia
3
Hypopharyngeal Neoplasms
3
Carcinoma, Transitional Cell
3
Interventions
venetoclax
6
ibrutinib
4
pirtobrutinib
2
Sirolimus
2
Rituximab
2
Mycophenolic Acid
2
Cyclosporine
2
Cyclophosphamide
2
zanubrutinib
1
pembrolizumab
1
loncastuximab tesirine
1
fludarabine phosphate
1
carfilzomib
1
acalabrutinib
1
Whole-Body Irradiation
1
Tacrolimus
1
Specimen Handling
1
Rifaximin
1
Peripheral Blood Stem Cell Transplantation
1
Methotrexate
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Etoposide
1
Dexamethasone
1
Cyclosporins
1
Calcium Dobesilate
1
CT-P10
1
Busulfan
1
Biopsy
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Waldenstrom Macroglobulinemia
×
Cisplatin
×
30 days
×
Clear all
No trials found.